US Stock MarketDetailed Quotes

DXR Daxor

Watchlist
  • 7.950
  • 0.0000.00%
Close Dec 26 16:00 ET
38.48MMarket Cap6.85P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Trytosaveabit
    Trytosaveabit
    Oct 9 07:19
    There’s a chance some nice big sales come from this?
    $Daxor (DXR.US)$ DAXOR'S INNOVATIVE BVA-100 BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
    GlobeNewswire· 
    Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence
    Oak Ridge, TN, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, announces today it will be exhibiting at the MedAxiom Cardiovascular (CV) Transforum Fall'24 Confere...
    Jaguar8
    Jaguar8
    Sep 12 07:17
    NEWS
    $Daxor (DXR.US)$
    Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
    Daxor (Nasdaq: DXR) announces a pivotal review published in Cardiorenal Medicine highlighting the important role of Blood Volume Analysis (BVA) in managing cardiorenal syndrome (CRS). The review, authored by expert contributors, emphasizes BVA's significance in enhancing the precision of diuretic and red cell therapies, leading to impro...
    Jaguar8
    Jaguar8
    Jul 11 07:02
    NEWS
    $Daxor (DXR.US)$
    Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide
    Daxor (Nasdaq: DXR) announced the expansion of its blood volume analysis (BVA) technology, including the launch of new BVA programs and the increased adoption of its ezBVA Lab service. This CLIA-certified facility provides next-day blood volume analysis results on-demand. Recent expansions include a regional referral center for Northeast Arkansas and Southeast Missouri...
    Jaguar8
    Jaguar8
    Apr 16 07:01
    $Daxor (DXR.US)$
    NEWS
    New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion
    Daxor (Nasdaq: DXR) announces two new studies validating the clinical benefits of blood volume analysis (BVA) in ambulatory heart failure patients. The studies highlight the lack of correlation between surrogate measures and actual blood volume, emphasizing the importance of accurate volume measurement. Data presented at th...
    Moontomas
    Moontomas
    Sep 2, 2023 11:03
    Future Movement the crucial last few months of the year
    Hello everyone,
    We're seeking community insights on the potential movement of this stock in the coming one to two months. Do you anticipate it to rise or fall?
    If you have any solid ideas, insider information, or news that might influence this stock's direction, kindly share in the comments section below. Your input is greatly valued!
    Thank you for your participation.
    $Daxor (DXR.US)$
Read more
Heat List
US
Overall
Symbol
Price
% Chg

No Data